Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-27 Purchase |
2021-08-30 09:08 am |
Immunovant Inc. | IMVT | Hughes Douglas J. Director |
18,247 | $8.24 | $150,355 | 58,447 (Direct) |
View |
| 2021-08-20 Purchase |
2021-08-20 6:14 pm |
Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director |
7,000 | $7.65 | $53,550 | 67,200 (Direct) |
View |
| 2021-08-13 Purchase |
2021-08-16 5:29 pm |
Immunovant Inc. | IMVT | Pande Atul Director |
5,000 | $7.98 | $39,900 | 45,200 (Indirect) |
View |
| 2021-08-10 Purchase |
2021-08-11 2:12 pm |
Immunovant Inc. | IMVT | Fromkin Andrew J. Director |
5,500 | $7.9 | $43,450 | 45,700 (Direct) |
View |
| 2020-09-11 Purchase |
2020-09-15 5:09 pm |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
5,000 | $38.17 | $190,850 | 5,000 (Direct) |
View |
| 2020-09-04 Purchase |
2020-09-04 5:29 pm |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. 10% Owner |
380,000 | $33 | $12,540,000 | 47,593,419 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-11 Option Award |
2021-09-16 5:15 pm |
N/A 2031-06-11 |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
369,320 | $0 | 369,320 (Direct) |
View |
| 2021-09-11 Option Award |
2021-09-14 4:02 pm |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
510,800 | $0 | 510,800 (Direct) |
View |
| 2021-09-11 Option Award |
2021-09-14 3:59 pm |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
895,400 | $0 | 895,400 (Direct) |
View |
| 2021-08-03 Option Award |
2021-08-04 4:10 pm |
N/A N/A |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
285,306 | $0 | 344,806 (Direct) |
View |
| 2021-08-03 Option Award |
2021-08-04 4:06 pm |
N/A N/A |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
570,613 | $0 | 703,113 (Direct) |
View |
| 2021-08-02 Other |
2021-08-02 9:46 pm |
N/A N/A |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. 10% Owner |
17,021,276 | $0 | 90,409,940 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 08:56 am |
N/A 2031-06-11 |
Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer |
481,365 | $0 | 481,365 (Direct) |
View |
| 2021-03-19 Option Award(A) |
2021-03-31 12:37 pm |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Jain Rita Chief Medical Officer |
451,665 | $0 | 471,665 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:58 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director |
38,800 | $0 | 83,500 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:54 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Torti Frank Director |
48,100 | $0 | 76,500 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:53 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Pande Atul Director |
38,800 | $0 | 63,500 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:52 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Hughes Douglas J. Director |
38,800 | $0 | 63,500 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:50 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Fromkin Andrew J. Director |
38,800 | $0 | 63,500 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:46 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
597,200 | $0 | 597,200 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:45 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Yanchik Connealy Pamela Chief Financial Officer |
208,200 | $0 | 208,200 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:43 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Elliott Michael James Chief Scientific Officer |
439,900 | $0 | 439,900 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:41 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Jain Rita Chief Medical Officer |
451,665 | $0 | 471,665 (Direct) |
View |
| 2021-03-19 Option Award |
2021-03-23 08:39 am |
N/A 2031-03-19 |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
245,600 | $0 | 250,600 (Direct) |
View |
| 2021-01-22 Option Award |
2021-01-25 4:39 pm |
N/A 2031-01-22 |
Immunovant Inc. | IMVT | Jain Rita Chief Medical Officer |
240,000 | $0 | 240,000 (Direct) |
View |
| 2020-09-17 Other |
2020-09-18 4:33 pm |
N/A N/A |
Immunovant Inc. | IMVT | Roivant Sciences Ltd. 10% Owner |
8,773,969 | $0 | 65,141,357 (Direct) |
View |
| 2020-09-04 Option Award |
2020-09-04 5:03 pm |
N/A 2030-09-04 |
Immunovant Inc. | IMVT | Elliott Michael James Chief Scientific Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:52 am |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director |
61,700 | $0 | 81,700 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:47 am |
N/A 2020-05-14 |
Immunovant Inc. | IMVT | Pande Atul Director |
61,700 | $0 | 61,700 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:42 am |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | Hughes Douglas J. Director |
61,700 | $0 | 61,700 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:40 am |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | Fromkin Andrew J. Director |
61,700 | $0 | 61,700 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:37 am |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | Torti Frank Director |
71,000 | $0 | 71,000 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:31 am |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | Yanchik Connealy Pamela Chief Financial Officer |
180,500 | $0 | 180,500 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:28 am |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | MIDDLEKAUFF W BRADFORD General Counsel |
142,600 | $0 | 142,600 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:26 am |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer |
430,700 | $0 | 430,700 (Direct) |
View |
| 2020-05-15 Option Award |
2020-05-18 08:22 am |
N/A 2030-05-14 |
Immunovant Inc. | IMVT | Butchko Julia G. Chief Dev. & Tech. Officer |
319,700 | $0 | 319,700 (Direct) |
View |